Topic: IDE

Medtronic said it has received Europe’s CE mark for its Affera system that integrates pulsed […]

Vivasure Medical announced today that it received FDA investigational device exemption (IDE) to advance a clinical […]

Premia Spine has announced the publication of two-year outcomes from the TOPS facet joint replacement […]

Virtual Incision Corporation, a medical device company developing a miniaturized robotic-assisted surgery (RAS) system, has […]

HistoSonics announced today that it received FDA approval for an investigational device exemption (IDE) trial of […]

MedAlliance announced today that its novel sirolimus-eluting balloon received conditional FDA investigational device exemption (IDE). […]

Burning Rock (Nasdaq:BNR) announced today that the FDA granted breakthrough device designation to its OverC blood test. […]

Dive Brief: Click Therapeutics has received breakthrough device status for its prescription digital migraine therapy. The Food […]

Cambridge-based Sinaptica Therapeutics, a company providing electromagnetic treatment for patients with neurodegenerative diseases, announced its […]

Attune Medical announced today that the FDA granted investigational device exemption (IDE) to study the company’s […]

Gimer Medical today announced that the company’s spinal cord stimulation (SCS) system was granted conditional […]

CereVasc today announced completion of the first eShunt procedure in the USA as part of […]

MedAlliance announced today that the first U.S. patient was enrolled in a U.S. clinical trial […]

The US Food and Drug Administration has granted almost 700 designations over the past seven […]

MedAlliance announced today that received conditional FDA investigational device exemption (IDE) for its Selution SLR […]

CereVasc announced today that the US Food and Drug Administration (FDA) has approved an investigational […]

Virtual Incision is going where few if any robotic-assisted surgical (RAS) devices have ever gone […]

3Spine has announced completion of the first series of US surgeries in the BalancedBack total […]

NeuroVasc Technologies recently announced that the first patient has been treated in its US investigational […]

Varian announced today that it received FDA investigational device exemption IDE to advance its Flash clinical […]

Neuspera Medical recently announced it will begin enrolment in its pivotal clinical trial, SANS-UUI—a single-arm […]

Neuros Medical has announced the completion of its QUEST pivotal trial’s 90-day primary endpoints, according […]

MedAlliance announced today that it received FDA investigational device exemption (IDE) for its Selution SLR […]